# FDA Inspection 816790 - Meiji Seika Pharma Co., Ltd. - December 14, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/meiji-seika-pharma-co-ltd/fe3a9e82-8328-4be0-ae84-84945660f594/
Source feed: FDA_Inspections

> FDA Inspection 816790 for Meiji Seika Pharma Co., Ltd. on December 14, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 816790
- Company Name: Meiji Seika Pharma Co., Ltd.
- Inspection Date: 2012-12-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1065559 - 2018-07-20](https://www.globalkeysolutions.net/api/records/fda_inspections/meiji-seika-pharma-co-ltd/c9e1e8ce-7814-44aa-8c5f-7fb020f0a6e2/)
- [FDA Inspection 974522 - 2016-06-03](https://www.globalkeysolutions.net/api/records/fda_inspections/meiji-seika-pharma-co-ltd/c50fec4f-c31d-431c-a7d9-26e73d6f0982/)

Company: https://www.globalkeysolutions.net/companies/meiji-seika-pharma-co-ltd/9f210099-6346-4340-9f86-521eb46b2629

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c